Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015)

Name: Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015) | Business Quant
Creator: Business Quant

Penumbra (PEN) reported Current Deferred Tax Assets of $7.3 million for Q3 2015, up 16.77% on a QoQ basis from $6.3 million in Q4 2014.

Penumbra (PEN) has 2 years of Current Deferred Tax Assets data on file, last reported at $7.3 million in Q3 2015.

Quarterly Current Deferred Tax Assets changed N/A year-over-year to $7.3 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $7.3 million (changed N/A YoY) and the FY2014 annual result came in at $6.3 million, changed N/A from the prior year.
Current Deferred Tax Assets climbed to $7.3 million in Q3 2015 per PEN's latest filing, from $6.3 million in the prior quarter.
Across five years, Current Deferred Tax Assets topped out at $7.3 million in Q3 2015 and bottomed at $6.3 million in Q4 2014.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	Penumbra	12.52 Bn	11.91 Bn	253.41 Mn

Download Data 🔒